Diagnostic Imaging North America
September 2007
COVER STORY
By: Emily Hayes
DEPARTMENTS
X-ray Vision
By: John C. Hayes, Editor
Agenda
By: Emily Hayes
Overread
Newsclips
Imaging & The Law
By: Thomas W. Greeson, J.D.
Tumor Ablation
By: Martin G. Mack, M.D., Katrin Eichler, M.D., Stephan Zangos, M.D., and Thomas J. Vogl, M.D.
Tech Watch
Clinical Practice
JEFFREY C. HELLINGER, M.D., and DANIEL MARGOLIS, M.D.
Neuroeconomics
By: Greg Freiherr
Backscatter
By: Bradley M. Tipler, M.D.
Special Section
Enterprise Imaging & IT Supplement
Informatics News
Archives
Teleradiology
Practice Economics
Image Management
Informatics Training
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.